11 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... #Pharmacology #Dosing ... #Dosing #Renal ... #Impairment #CKD ... #Table #GFR #Hypoglycemics
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
Insulin Dosing Basics ... Products Insulin dosing ... For type 2 diabetes ... Insulin #Basics #Dosing ... #Conversion #Initiating
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
class is still going ... initiating an ARB ... Receptor #Blockers #ARB ... #Conversion #Table ... #Dosing #Pharmacology
Angiotensin II Receptor Blocker (ARB) - Comparable Dose Chart 
 - Valsartan (Diovan®) 40 mg daily
Receptor Blocker (ARB ... 20 mg daily #ARB ... #Equivalent #Conversion ... #Dosing #Doseage ... #Table #AngiotensinII
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
patients with CKD ... agents since they are ... not able to effectively ... Purposes Only* #CKD ... Hyperphosphatemia #Dose #Dosing
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
RECEPTOR ANTAGONIST (ARB ... ) DOSING: TOOL ... #ARB #AngiotensinII ... #Pharmacology #Conversion ... Switching #Equivalent #Table
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
oral suspension DOSING ... patients with CKD ... , HF, or diabetes ... inhibitors, etc.) are
Hypersensitivity Types and Their Mechanisms
Type I - lgE - Soluble antigen
 - Allergen-specific lgE antibodies bind
blood types or during ... Antigen-antibody complexes are ... dermatitis, type I diabetes ... Hypersensitivity #Types #Classification ... Diagnosis #Reactions #Table
Concentrated Insulin

Developed with the goal of easing therapy by reducing the volume & number of injections
with the goal of easing ... volume lead to low variability ... of insulin/ day are ... lower risk of dosing ... #pharmacology #conversion
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... oral route by using ... drug to remain stable ... GLP1 agonists are ... #semaglutide #Diabetes